Myriad Genetics, Inc. (MYGN)
NASDAQ·Healthcare·Medical - Diagnostics & Research
$5.97
-5.01%
Mkt Cap $637.98M
Analyst Ratings
Buy
1
Hold
6
Sell
1
Price Target (24 analysts)
$4.82
Range $3.00 – $8.00
Implied Upside
-19.2%
Consensus $4.82 vs current $5.97